Endothelin A receptor: Difference between revisions
CSV import |
CSV import |
||
| Line 29: | Line 29: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 10:50, 17 March 2025
Endothelin A receptor (ETA receptor) is a type of endothelin receptor that has a high affinity for endothelin-1. It is a G protein-coupled receptor (GPCR) that is primarily found in the vascular smooth muscle where it plays a role in vasoconstriction and cell proliferation.
Structure[edit]
The ETA receptor is a 427-amino acid protein that belongs to the GPCR family. It has seven transmembrane domains, an extracellular N-terminus, and an intracellular C-terminus. The receptor's structure allows it to bind to endothelin-1 and initiate a cascade of intracellular events.
Function[edit]
The primary function of the ETA receptor is to mediate the effects of endothelin-1, a potent vasoconstrictor. When endothelin-1 binds to the ETA receptor, it activates the G protein, which in turn activates a series of intracellular signaling pathways. These pathways lead to the contraction of vascular smooth muscle cells, resulting in vasoconstriction.
In addition to its role in vasoconstriction, the ETA receptor also plays a role in cell proliferation. It has been found to be overexpressed in several types of cancer, including ovarian cancer, prostate cancer, and melanoma.
Clinical significance[edit]
Due to its role in vasoconstriction and cell proliferation, the ETA receptor is a potential target for the treatment of various cardiovascular and cancerous diseases. Several ETA receptor antagonists have been developed and are currently in clinical trials.
See also[edit]
References[edit]
<references />
This GPCR-related article is a stub. You can help WikiMD by expanding it.
